105 related articles for article (PubMed ID: 4648594)
1. Studies of primary hyperlipoproteinemias. IV. Treatment.
Ciświcka-Sznajderman M
Pol Med J; 1972; 11(5):1100-5. PubMed ID: 4648594
[No Abstract] [Full Text] [Related]
2. [Hyperlipoproteinemias: significance--diagnosis--therapy].
Schwandt P
Internist (Berl); 1971 Nov; 12(11):481-7. PubMed ID: 4943880
[No Abstract] [Full Text] [Related]
3. [Hyperlipoproteinemias. II].
Weber K; Braun-Falco O
Hautarzt; 1972 Jan; 23(1):8-11. PubMed ID: 4551361
[No Abstract] [Full Text] [Related]
4. [Classification of hyperlipoproteinaemia in primary gout].
Mertz DP; Schwoerer P; Babucke G
Dtsch Med Wochenschr; 1972 Apr; 97(15):600-4. PubMed ID: 5026795
[No Abstract] [Full Text] [Related]
5. The primary hyperlipoproteinemias.
Bybee DE; Hamilton RD
J Ky Med Assoc; 1974 Dec; 72(12):658-62. PubMed ID: 4373515
[No Abstract] [Full Text] [Related]
6. Hypolipidemic drugs and hyperlipoproteinemia.
Levy RI; Langer T
Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
[No Abstract] [Full Text] [Related]
7. [Lipoproteins and hyperlipoproteinemias].
Weisweiler P; Schwandt P
Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
[No Abstract] [Full Text] [Related]
8. [Primary hyperlipoproteinemia. IV. Treatment].
Ciświcka-Sznajderman M
Pol Arch Med Wewn; 1971 Dec; 47(6):589-94. PubMed ID: 5139034
[No Abstract] [Full Text] [Related]
9. [Therapeutic results in directed and nondirected therapy of hyperlipoproteinemia].
Knüchel F; Ochs H
Med Welt; 1973 Jun; 24(24):1019-23. PubMed ID: 4751426
[No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of hyperlipoproteinemias].
Hauser J; Pometta D
Schweiz Med Wochenschr; 1972 Feb; 102(8):265-70. PubMed ID: 5010516
[No Abstract] [Full Text] [Related]
11. The role of diet in the management of hyperlipoproteinaemias.
Stone MC
Proc Nutr Soc; 1972 Dec; 31(3):311-6. PubMed ID: 4353223
[No Abstract] [Full Text] [Related]
12. [Hiperlipidemia as a risk factor in coronary artery disease].
Michajlik A
Wiad Lek; 1973 Mar; 26(6):529-34. PubMed ID: 4572266
[No Abstract] [Full Text] [Related]
13. [Clinical picture of the type-3-hyperlipoproteinemia].
Reimers HJ; Huth K; Schoenborn W; Fuhrmann W
Verh Dtsch Ges Inn Med; 1971; 77():596-9. PubMed ID: 5155905
[No Abstract] [Full Text] [Related]
14. [Hyperlipoproteinemias. I].
Weber K; Braun-Falco O
Hautarzt; 1971 Dec; 22(12):517-20. PubMed ID: 4945742
[No Abstract] [Full Text] [Related]
15. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
Aubry F; Lapierre YL; Noël C; Davignon J
Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
[No Abstract] [Full Text] [Related]
16. [Limits in Frederickson's classification in the typization of human hyperlipoproteinemias. Personal experience].
Pagnan A; Tonolli E
Minerva Med; 1974 Jul; 65(53):2850-4. PubMed ID: 4843557
[No Abstract] [Full Text] [Related]
17. The hyperlipoproteinemias. A simplified classification and approach to therapy.
Zelis R; Mason DT; Spann JF
Calif Med; 1970 May; 112(5):32-7. PubMed ID: 4924875
[TBL] [Abstract][Full Text] [Related]
18. [Incidence and type distribution of hyperlipoproteinemias in hospitalized patients of a university hospital].
Schlierf G; Weinans G; Weinans T; Reinheimer W; Kahlke W
Dtsch Med Wochenschr; 1972 Sep; 97(37):1371-5. PubMed ID: 5055723
[No Abstract] [Full Text] [Related]
19. Serum lipid precursors of coronary heart disease.
Kannel WB; Garcia MJ; McNamara PM; Pearson G
Hum Pathol; 1971 Mar; 2(1):129-51. PubMed ID: 5095238
[No Abstract] [Full Text] [Related]
20. Therapeutics XIX. Lipid lowering agents.
Frenk E; Walker AE; Edwards IR
Br J Dermatol; 1972 Aug; 87(2):180-5. PubMed ID: 4560478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
